{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:40:39Z","timestamp":1789522839716,"version":"build-2803163510"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100005339","name":"American Academy of Neurology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11910-025-01444-4","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T16:42:44Z","timestamp":1754325764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Updates on Mitochondrial Myopathies"],"prefix":"10.1007","volume":"25","author":[{"given":"Emanuele","family":"Barca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Emmanuele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"issue":"5","key":"1444_CR1","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/ana.24362","volume":"77","author":"GS Gorman","year":"2015","unstructured":"Gorman GS, Schaefer AM, Ng Y, Gomez N, Blakely EL, Alston CL, et al. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol. 2015;77(5):753\u20139.","journal-title":"Ann Neurol"},{"key":"1444_CR2","doi-asserted-by":"publisher","first-page":"102784","DOI":"10.1016\/j.ebiom.2020.102784","volume":"56","author":"SL Stenton","year":"2020","unstructured":"Stenton SL, Prokisch H. Genetics of mitochondrial diseases: identifying mutations to help diagnosis. EBioMedicine. 2020;56:102784.","journal-title":"EBioMedicine"},{"issue":"2","key":"1444_CR3","doi-asserted-by":"publisher","first-page":"fcae041","DOI":"10.1093\/braincomms\/fcae041","volume":"6","author":"G Beecher","year":"2024","unstructured":"Beecher G, Gavrilova RH, Mandrekar J, Naddaf E. Mitochondrial myopathies diagnosed in adulthood: clinico-genetic spectrum and long-term outcomes. Brain Commun. 2024;6(2):fcae041.","journal-title":"Brain Commun"},{"issue":"Suppl 1","key":"1444_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1159\/000243300","volume":"58","author":"DC De Vivo","year":"1990","unstructured":"De Vivo DC, DiMauro S. Mitochondrial defects of brain and muscle. Biol Neonate. 1990;58(Suppl 1):54\u201369.","journal-title":"Biol Neonate"},{"key":"1444_CR5","doi-asserted-by":"crossref","unstructured":"Bottoni P, Gionta G, Scatena R. Remarks on mitochondrial myopathies. Int J Mol Sci. 2022;24(1).","DOI":"10.3390\/ijms24010124"},{"issue":"7","key":"1444_CR6","doi-asserted-by":"publisher","first-page":"e16951","DOI":"10.15252\/emmm.202216951","volume":"15","author":"N Southwell","year":"2023","unstructured":"Southwell N, Primiano G, Nadkarni V, Attarwala N, Beattie E, Miller D, et al. A coordinated multiorgan metabolic response contributes to human mitochondrial myopathy. EMBO Mol Med. 2023;15(7):e16951.","journal-title":"EMBO Mol Med"},{"issue":"2","key":"1444_CR7","doi-asserted-by":"publisher","first-page":"e402","DOI":"10.1212\/NXG.0000000000000402","volume":"6","author":"E Barca","year":"2020","unstructured":"Barca E, Long Y, Cooley V, Schoenaker R, Emmanuele V, DiMauro S, et al. Mitochondrial diseases in North america: an analysis of the NAMDC registry. Neurol Genet. 2020;6(2):e402.","journal-title":"Neurol Genet"},{"issue":"2","key":"1444_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ymgme.2022.05.001","volume":"136","author":"V Emmanuele","year":"2022","unstructured":"Emmanuele V, Ganesh J, Vladutiu G, Haas R, Kerr D, Saneto RP, et al. Time to harmonize mitochondrial syndrome nomenclature and classification: a consensus from the North American mitochondrial disease consortium (NAMDC). Mol Genet Metab. 2022;136(2):125\u201331.","journal-title":"Mol Genet Metab"},{"key":"1444_CR9","unstructured":"El-Hattab AW, Craigen WJ, Wong LJC, Scaglia F. Mitochondrial DNA Maintenance Defects Overview. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews((R)). Seattle (WA)1993."},{"issue":"5","key":"1444_CR10","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.ajhg.2009.04.004","volume":"84","author":"A Di Fonzo","year":"2009","unstructured":"Di Fonzo A, Ronchi D, Lodi T, Fassone E, Tigano M, Lamperti C, et al. The mitochondrial disulfide relay system protein GFER is mutated in autosomal-recessive myopathy with cataract and combined respiratory-chain deficiency. Am J Hum Genet. 2009;84(5):594\u2013604.","journal-title":"Am J Hum Genet"},{"key":"1444_CR11","unstructured":"Goldstein A, Falk MJ. Single Large-Scale Mitochondrial DNA Deletion Syndromes. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews((R)). Seattle (WA)1993."},{"issue":"2","key":"1444_CR12","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/mus.24262","volume":"50","author":"L Peverelli","year":"2014","unstructured":"Peverelli L, Gold CA, Naini AB, Tanji K, Akman HO, Hirano M, et al. Mitochondrial myopathy with dystrophic features due to a novel mutation in the MTTM gene. Muscle Nerve. 2014;50(2):292\u20135.","journal-title":"Muscle Nerve"},{"issue":"4","key":"1444_CR13","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1212\/NXG.0000000000000082","volume":"2","author":"SA Hardy","year":"2016","unstructured":"Hardy SA, Blakely EL, Purvis AI, Rocha MC, Ahmed S, Falkous G, et al. Pathogenic MtDNA mutations causing mitochondrial myopathy: the need for muscle biopsy. Neurol Genet. 2016;2(4):e82.","journal-title":"Neurol Genet"},{"key":"1444_CR14","doi-asserted-by":"publisher","first-page":"1386293","DOI":"10.3389\/fneur.2024.1386293","volume":"15","author":"WCP Cavalcante","year":"2024","unstructured":"Cavalcante WCP, da Silva AMS, Mendonca RH, Moreno CAM, Proenca BMS, Guimaraes JB, et al. Whole-body muscle magnetic resonance imaging in inflammatory myopathy with mitochondrial pathology. Front Neurol. 2024;15:1386293.","journal-title":"Front Neurol"},{"issue":"7","key":"1444_CR15","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1007\/s00415-021-10957-0","volume":"269","author":"C Dominguez-Gonzalez","year":"2022","unstructured":"Dominguez-Gonzalez C, Fernandez-Torron R, Moore U, de Fuenmayor-Fernandez CP, Velez-Gomez B, Cabezas JA, et al. Muscle MRI characteristic pattern for late-onset TK2 deficiency diagnosis. J Neurol. 2022;269(7):3550\u201362.","journal-title":"J Neurol"},{"issue":"Pt 2","key":"1444_CR16","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/brain\/awt321","volume":"137","author":"JP Grady","year":"2014","unstructured":"Grady JP, Campbell G, Ratnaike T, Blakely EL, Falkous G, Nesbitt V, et al. Disease progression in patients with single, large-scale mitochondrial DNA deletions. Brain. 2014;137(Pt 2):323\u201334.","journal-title":"Brain"},{"issue":"6","key":"1444_CR17","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/0092-8674(90)90059-N","volume":"61","author":"JM Shoffner","year":"1990","unstructured":"Shoffner JM, Lott MT, Lezza AM, Seibel P, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell. 1990;61(6):931\u20137.","journal-title":"Cell"},{"issue":"14","key":"1444_CR18","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1056\/NEJM199909303411404","volume":"341","author":"AL Andreu","year":"1999","unstructured":"Andreu AL, Hanna MG, Reichmann H, Bruno C, Penn AS, Tanji K, et al. Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. N Engl J Med. 1999;341(14):1037\u201344.","journal-title":"N Engl J Med"},{"issue":"1","key":"1444_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1086\/301910","volume":"63","author":"MG Hanna","year":"1998","unstructured":"Hanna MG, Nelson IP, Rahman S, Lane RJ, Land J, Heales S, et al. Cytochrome c oxidase deficiency associated with the first stop-codon point mutation in human MtDNA. Am J Hum Genet. 1998;63(1):29\u201336.","journal-title":"Am J Hum Genet"},{"key":"1444_CR20","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/978-1-4614-3573-0_14","volume":"748","author":"S DiMauro","year":"2012","unstructured":"DiMauro S, Tanji K, Schon EA. The many clinical faces of cytochrome c oxidase deficiency. Adv Exp Med Biol. 2012;748:341\u201357.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"1444_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/1531-8249(199901)45:1<127::AID-ART20>3.0.CO;2-Y","volume":"45","author":"AL Andreu","year":"1999","unstructured":"Andreu AL, Bruno C, Dunne TC, Tanji K, Shanske S, Sue CM, et al. A nonsense mutation (G15059A) in the cytochrome b gene in a patient with exercise intolerance and myoglobinuria. Ann Neurol. 1999;45(1):127\u201330.","journal-title":"Ann Neurol"},{"issue":"6","key":"1444_CR22","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/1531-8249(199906)45:6<820::AID-ANA22>3.0.CO;2-W","volume":"45","author":"AL Andreu","year":"1999","unstructured":"Andreu AL, Tanji K, Bruno C, Hadjigeorgiou GM, Sue CM, Jay C, et al. Exercise intolerance due to a nonsense mutation in the MtDNA ND4 gene. Ann Neurol. 1999;45(6):820\u20133.","journal-title":"Ann Neurol"},{"key":"1444_CR23","doi-asserted-by":"crossref","unstructured":"Bermejo-Guerrero L, de Fuenmayor-Fernandez CP, Guerrero-Molina MP, Martin-Jimenez P, Blazquez A, Serrano-Lorenzo P et al. Serum GDF-15 levels accurately differentiate patients with primary mitochondrial myopathy, manifesting with exercise intolerance and fatigue, from patients with chronic fatigue syndrome. J Clin Med. 2023;12(6).","DOI":"10.3390\/jcm12062435"},{"key":"1444_CR24","unstructured":"Morales Corado JA, Lee CU, Enns GM. Carnitine-Acylcarnitine Translocase Deficiency. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews((R)). Seattle (WA)1993."},{"key":"1444_CR25","doi-asserted-by":"crossref","unstructured":"Invernizzi F, Izzo R, Colangelo I, Legati A, Zanetti N, Garavaglia B et al. NGS-Based genetic analysis in a cohort of Italian patients with suspected inherited myopathies and\/or hyperckemia. Genes (Basel). 2023;14(7).","DOI":"10.3390\/genes14071393"},{"issue":"4","key":"1444_CR26","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s13311-018-00674-4","volume":"15","author":"ST Ahmed","year":"2018","unstructured":"Ahmed ST, Craven L, Russell OM, Turnbull DM, Vincent AE. Diagnosis and treatment of mitochondrial myopathies. Neurotherapeutics. 2018;15(4):943\u201353.","journal-title":"Neurotherapeutics"},{"issue":"3","key":"1444_CR27","doi-asserted-by":"publisher","first-page":"232470961560790","DOI":"10.1177\/2324709615607908","volume":"3","author":"F Galan","year":"2015","unstructured":"Galan F, de Lavera I, Cotan D, Sanchez-Alcazar JA. Mitochondrial myopathy in Follow-up of a patient with chronic fatigue syndrome. J Investig Med High Impact Case Rep. 2015;3(3):2324709615607908.","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"5","key":"1444_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1365-2796.1995.tb01218.x","volume":"238","author":"R Luft","year":"1995","unstructured":"Luft R, Landau BR. Mitochondrial medicine. J Intern Med. 1995;238(5):405\u201321.","journal-title":"J Intern Med"},{"issue":"2","key":"1444_CR29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0022-510X(76)90063-0","volume":"27","author":"S DiMauro","year":"1976","unstructured":"DiMauro S, Bonilla E, Lee CP, Schotland DL, Scarpa A, Conn H Jr., et al. Luft\u2019s disease. Further biochemical and ultrastructural studies of skeletal muscle in the second case. J Neurol Sci. 1976;27(2):217\u201332.","journal-title":"J Neurol Sci"},{"issue":"10","key":"1444_CR30","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.nmd.2021.08.005","volume":"31","author":"C Olimpio","year":"2021","unstructured":"Olimpio C, Tiet MY, Horvath R. Primary mitochondrial myopathies in childhood. Neuromuscul Disord. 2021;31(10):978\u201387.","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"1444_CR31","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/joim.13054","volume":"287","author":"S Rahman","year":"2020","unstructured":"Rahman S. Mitochondrial disease in children. J Intern Med. 2020;287(6):609\u201333.","journal-title":"J Intern Med"},{"issue":"5","key":"1444_CR32","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/WCO.0000000000000126","volume":"27","author":"RD Pitceathly","year":"2014","unstructured":"Pitceathly RD, McFarland R. Mitochondrial myopathies in adults and children: management and therapy development. Curr Opin Neurol. 2014;27(5):576\u201382.","journal-title":"Curr Opin Neurol"},{"issue":"5","key":"1444_CR33","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/WCO.0000000000000743","volume":"32","author":"IP de Barcelos","year":"2019","unstructured":"de Barcelos IP, Emmanuele V, Hirano M. Advances in primary mitochondrial myopathies. Curr Opin Neurol. 2019;32(5):715\u201321.","journal-title":"Curr Opin Neurol"},{"key":"1444_CR34","doi-asserted-by":"crossref","unstructured":"Mancuso M, McFarland R, Klopstock T, Hirano M, consortium on Trial Readiness in Mitochondrial M. International Workshop:: Outcome measures and clinical trial readiness in primary mitochondrial myopathies in children and adults. Consensus recommendations. 16\u201318 November 2016, Rome, Italy. Neuromuscul Disord. 2017;27(12):1126-37.","DOI":"10.1016\/j.nmd.2017.08.006"},{"issue":"23","key":"1444_CR35","doi-asserted-by":"publisher","first-page":"e105364","DOI":"10.15252\/embj.2020105364","volume":"39","author":"D Hathazi","year":"2020","unstructured":"Hathazi D, Griffin H, Jennings MJ, Giunta M, Powell C, Pearce SF, et al. Metabolic shift underlies recovery in reversible infantile respiratory chain deficiency. EMBO J. 2020;39(23):e105364.","journal-title":"EMBO J"},{"issue":"9","key":"1444_CR36","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/gim.2014.177","volume":"17","author":"S Parikh","year":"2015","unstructured":"Parikh S, Goldstein A, Koenig MK, Scaglia F, Enns GM, Saneto R, et al. Diagnosis and management of mitochondrial disease: a consensus statement from the mitochondrial medicine society. Genet Med. 2015;17(9):689\u2013701.","journal-title":"Genet Med"},{"issue":"1","key":"1444_CR37","doi-asserted-by":"publisher","first-page":"e00325","DOI":"10.1016\/j.neurot.2024.e00325","volume":"21","author":"BJ Shayota","year":"2024","unstructured":"Shayota BJ. Biomarkers of mitochondrial disorders. Neurotherapeutics. 2024;21(1):e00325.","journal-title":"Neurotherapeutics"},{"issue":"1\u20132","key":"1444_CR38","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ymgme.2013.07.011","volume":"110","author":"C Clarke","year":"2013","unstructured":"Clarke C, Xiao R, Place E, Zhang Z, Sondheimer N, Bennett M, et al. Mitochondrial respiratory chain disease discrimination by retrospective cohort analysis of blood metabolites. Mol Genet Metab. 2013;110(1\u20132):145\u201352.","journal-title":"Mol Genet Metab"},{"issue":"5","key":"1444_CR39","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1023\/B:BOLI.0000043017.90837.93","volume":"27","author":"C Thauvin-Robinet","year":"2004","unstructured":"Thauvin-Robinet C, Faivre L, Barbier ML, Chevret L, Bourgeois J, Netter JC, et al. Severe lactic acidosis and acute Thiamin deficiency: a report of 11 neonates with unsupplemented total parenteral nutrition. J Inherit Metab Dis. 2004;27(5):700\u20134.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"1444_CR40","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/ana.24506","volume":"78","author":"S Yatsuga","year":"2015","unstructured":"Yatsuga S, Fujita Y, Ishii A, Fukumoto Y, Arahata H, Kakuma T, et al. Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders. Ann Neurol. 2015;78(5):814\u201323.","journal-title":"Ann Neurol"},{"issue":"9","key":"1444_CR41","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S1474-4422(11)70155-7","volume":"10","author":"A Suomalainen","year":"2011","unstructured":"Suomalainen A, Elo JM, Pietilainen KH, Hakonen AH, Sevastianova K, Korpela M, et al. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol. 2011;10(9):806\u201318.","journal-title":"Lancet Neurol"},{"issue":"2","key":"1444_CR42","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10545-012-9578-7","volume":"37","author":"K Al-Thihli","year":"2014","unstructured":"Al-Thihli K, Sinclair G, Sirrs S, Mezei M, Nelson J, Vallance H. Performance of serum and dried blood spot acylcarnitine profiles for detection of fatty acid beta-oxidation disorders in adult patients with rhabdomyolysis. J Inherit Metab Dis. 2014;37(2):207\u201313.","journal-title":"J Inherit Metab Dis"},{"issue":"5\u20136","key":"1444_CR43","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.mito.2004.07.011","volume":"4","author":"M Tarnopolsky","year":"2004","unstructured":"Tarnopolsky M. Exercise testing as a diagnostic entity in mitochondrial myopathies. Mitochondrion. 2004;4(5\u20136):529\u201342.","journal-title":"Mitochondrion"},{"issue":"4","key":"1444_CR44","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/1531-8249(199910)46:4<667::AID-ANA19>3.0.CO;2-D","volume":"46","author":"MC van Beekvelt","year":"1999","unstructured":"van Beekvelt MC, van Engelen BG, Wevers RA, Colier WN. Quantitative near-infrared spectroscopy discriminates between mitochondrial myopathies and normal muscle. Ann Neurol. 1999;46(4):667\u201370.","journal-title":"Ann Neurol"},{"issue":"1","key":"1444_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00415-006-0229-5","volume":"254","author":"TD Jeppesen","year":"2007","unstructured":"Jeppesen TD, Quistorff B, Wibrand F, Vissing J. 31P-MRS of skeletal muscle is not a sensitive diagnostic test for mitochondrial myopathy. J Neurol. 2007;254(1):29\u201337.","journal-title":"J Neurol"},{"issue":"11\u201312","key":"1444_CR46","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.nmd.2022.10.006","volume":"32","author":"M Masingue","year":"2022","unstructured":"Masingue M, Rucheton B, Bris C, Romero NB, Procaccio V, Eymard B. Highly asymmetrical distribution of muscle wasting correlates to the heteroplasmy in a patient carrying a large-scale mitochondrial DNA deletion: a novel pathophysiological mechanism for explaining asymmetry in mitochondrial myopathies. Neuromuscul Disord. 2022;32(11\u201312):923\u201330.","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"1444_CR47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1203\/00006450-199008000-00011","volume":"28","author":"NG Larsson","year":"1990","unstructured":"Larsson NG, Holme E, Kristiansson B, Oldfors A, Tulinius M. Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome. Pediatr Res. 1990;28(2):131\u20136.","journal-title":"Pediatr Res"},{"issue":"12","key":"1444_CR48","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1001\/archneur.63.12.1701","volume":"63","author":"TD Jeppesen","year":"2006","unstructured":"Jeppesen TD, Schwartz M, Frederiksen AL, Wibrand F, Olsen DB, Vissing J. Muscle phenotype and mutation load in 51 persons with the 3243A\u2009>\u2009G mitochondrial DNA mutation. Arch Neurol. 2006;63(12):1701\u20136.","journal-title":"Arch Neurol"},{"issue":"2","key":"1444_CR49","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/path.4809","volume":"241","author":"CL Alston","year":"2017","unstructured":"Alston CL, Rocha MC, Lax NZ, Turnbull DM, Taylor RW. The genetics and pathology of mitochondrial disease. J Pathol. 2017;241(2):236\u201350.","journal-title":"J Pathol"},{"issue":"1","key":"1444_CR50","doi-asserted-by":"publisher","first-page":"e000990","DOI":"10.1136\/bmjno-2024-000990","volume":"7","author":"D Yeow","year":"2025","unstructured":"Yeow D, Rudaks LI, Davis R, Ng K, Ghaoui R, Cheong PL, et al. Long-read sequencing for diagnosis of genetic myopathies. BMJ Neurol Open. 2025;7(1):e000990.","journal-title":"BMJ Neurol Open"},{"issue":"8","key":"1444_CR51","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1038\/s41588-024-01827-2","volume":"56","author":"A Khan","year":"2024","unstructured":"Khan A, Unlu G, Lin P, Liu Y, Kilic E, Kenny TC, et al. Metabolic gene function discovery platform genemap identifies SLC25A48 as necessary for mitochondrial choline import. Nat Genet. 2024;56(8):1614\u201323.","journal-title":"Nat Genet"},{"issue":"6","key":"1444_CR52","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/MOP.0000000000000954","volume":"32","author":"I Barcelos","year":"2020","unstructured":"Barcelos I, Shadiack E, Ganetzky RD, Falk MJ. Mitochondrial medicine therapies: rationale, evidence, and dosing guidelines. Curr Opin Pediatr. 2020;32(6):707\u201318.","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"1444_CR53","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/mus.20688","volume":"35","author":"MC Rodriguez","year":"2007","unstructured":"Rodriguez MC, MacDonald JR, Mahoney DJ, Parise G, Beal MF, Tarnopolsky MA. Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders. Muscle Nerve. 2007;35(2):235\u201342.","journal-title":"Muscle Nerve"},{"issue":"2","key":"1444_CR54","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/ana.1050","volume":"50","author":"T Taivassalo","year":"2001","unstructured":"Taivassalo T, Shoubridge EA, Chen J, Kennaway NG, DiMauro S, Arnold DL, et al. Aerobic conditioning in patients with mitochondrial myopathies: physiological, biochemical, and genetic effects. Ann Neurol. 2001;50(2):133\u201341.","journal-title":"Ann Neurol"},{"issue":"Pt 11","key":"1444_CR55","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1093\/brain\/awn252","volume":"131","author":"JL Murphy","year":"2008","unstructured":"Murphy JL, Blakely EL, Schaefer AM, He L, Wyrick P, Haller RG, et al. Resistance training in patients with single, large-scale deletions of mitochondrial DNA. Brain. 2008;131(Pt 11):2832\u201340.","journal-title":"Brain"},{"key":"1444_CR56","doi-asserted-by":"publisher","first-page":"84","DOI":"10.12688\/wellcomeopenres.15825.1","volume":"5","author":"RJ Stefanetti","year":"2020","unstructured":"Stefanetti RJ, Blain A, Jimenez-Moreno C, Errington L, Ng YS, McFarland R, et al. Measuring the effects of exercise in neuromuscular disorders: a systematic review and meta-analyses. Wellcome Open Res. 2020;5:84.","journal-title":"Wellcome Open Res"},{"issue":"2","key":"1444_CR57","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s40291-020-00510-6","volume":"25","author":"RJ Tinker","year":"2021","unstructured":"Tinker RJ, Lim AZ, Stefanetti RJ, McFarland R. Current and emerging clinical treatment in mitochondrial disease. Mol Diagn Ther. 2021;25(2):181\u2013206.","journal-title":"Mol Diagn Ther"},{"issue":"10\u201312","key":"1444_CR58","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1080\/15257770.2015.1125001","volume":"35","author":"L Wang","year":"2016","unstructured":"Wang L. Mitochondrial purine and pyrimidine metabolism and beyond. Nucleosides Nucleotides Nucleic Acids. 2016;35(10\u201312):578\u201394.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"1444_CR59","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ebiom.2019.07.037","volume":"46","author":"C Lopez-Gomez","year":"2019","unstructured":"Lopez-Gomez C, Hewan H, Sierra C, Akman HO, Sanchez-Quintero MJ, Juanola-Falgarona M, et al. Bioavailability and cytosolic kinases modulate response to Deoxynucleoside therapy in TK2 deficiency. EBioMedicine. 2019;46:356\u201367.","journal-title":"EBioMedicine"},{"issue":"8","key":"1444_CR60","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1136\/jmedgenet-2017-105012","volume":"55","author":"C Garone","year":"2018","unstructured":"Garone C, Taylor RW, Nascimento A, Poulton J, Fratter C, Dominguez-Gonzalez C, et al. Retrospective natural history of thymidine kinase 2 deficiency. J Med Genet. 2018;55(8):515\u201321.","journal-title":"J Med Genet"},{"issue":"4","key":"1444_CR61","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/ana.26185","volume":"90","author":"C Lopez-Gomez","year":"2021","unstructured":"Lopez-Gomez C, Sanchez-Quintero MJ, Lee EJ, Kleiner G, Tadesse S, Xie J, et al. Synergistic Deoxynucleoside and gene therapies for thymidine kinase 2 deficiency. Ann Neurol. 2021;90(4):640\u201352.","journal-title":"Ann Neurol"},{"issue":"5","key":"1444_CR62","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/ana.24922","volume":"81","author":"C Lopez-Gomez","year":"2017","unstructured":"Lopez-Gomez C, Levy RJ, Sanchez-Quintero MJ, Juanola-Falgarona M, Barca E, Garcia-Diaz B, et al. Deoxycytidine and Deoxythymidine treatment for thymidine kinase 2 deficiency. Ann Neurol. 2017;81(5):641\u201352.","journal-title":"Ann Neurol"},{"issue":"2","key":"1444_CR63","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/ana.25506","volume":"86","author":"C Dominguez-Gonzalez","year":"2019","unstructured":"Dominguez-Gonzalez C, Madruga-Garrido M, Mavillard F, Garone C, Aguirre-Rodriguez FJ, Donati MA, et al. Deoxynucleoside therapy for thymidine kinase 2-Deficient myopathy. Ann Neurol. 2019;86(2):293\u2013303.","journal-title":"Ann Neurol"},{"issue":"3","key":"1444_CR64","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1212\/WNL.0000000000207402","volume":"101","author":"A Karaa","year":"2023","unstructured":"Karaa A, Bertini E, Carelli V, Cohen BH, Enns GM, Falk MJ, et al. Efficacy and safety of Elamipretide in individuals with primary mitochondrial myopathy: the MMPOWER-3 randomized clinical trial. Neurology. 2023;101(3):e238\u201352.","journal-title":"Neurology"},{"issue":"1","key":"1444_CR65","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/s13023-024-03421-5","volume":"19","author":"A Karaa","year":"2024","unstructured":"Karaa A, Bertini E, Carelli V, Cohen B, Ennes GM, Falk MJ, et al. Genotype-specific effects of Elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial. Orphanet J Rare Dis. 2024;19(1):431.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"1444_CR66","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0378-1119(92)90278-W","volume":"119","author":"AJ Thompson","year":"1992","unstructured":"Thompson AJ, Yuan X, Kudlicki W, Herrin DL. Cleavage and recognition pattern of a double-strand-specific endonuclease (I-creI) encoded by the Chloroplast 23S rRNA intron of chlamydomonas reinhardtii. Gene. 1992;119(2):247\u201351.","journal-title":"Gene"},{"issue":"3","key":"1444_CR67","doi-asserted-by":"publisher","first-page":"e49612","DOI":"10.15252\/embr.201949612","volume":"21","author":"N Nissanka","year":"2020","unstructured":"Nissanka N, Moraes CT. Mitochondrial DNA heteroplasmy in disease and targeted nuclease-based therapeutic approaches. EMBO Rep. 2020;21(3):e49612.","journal-title":"EMBO Rep"},{"issue":"9","key":"1444_CR68","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1007\/s10439-022-03051-7","volume":"52","author":"N Mikhailov","year":"2024","unstructured":"Mikhailov N, Hamalainen RH. Modulating mitochondrial DNA heteroplasmy with mitochondrially targeted endonucleases. Ann Biomed Eng. 2024;52(9):2627\u201340.","journal-title":"Ann Biomed Eng"},{"issue":"12","key":"1444_CR69","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1038\/s42255-023-00932-6","volume":"5","author":"WK Shoop","year":"2023","unstructured":"Shoop WK, Lape J, Trum M, Powell A, Sevigny E, Mischler A, et al. Efficient elimination of MELAS-associated m.3243G mutant mitochondrial DNA by an engineered MitoARCUS nuclease. Nat Metab. 2023;5(12):2169\u201383.","journal-title":"Nat Metab"},{"issue":"4","key":"1444_CR70","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/jimd.12211","volume":"43","author":"O Hikmat","year":"2020","unstructured":"Hikmat O, Naess K, Engvall M, Klingenberg C, Rasmussen M, Tallaksen CM, et al. Simplifying the clinical classification of polymerase gamma (POLG) disease based on age of onset; studies using a cohort of 155 cases. J Inherit Metab Dis. 2020;43(4):726\u201336.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"1444_CR71","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41582-018-0101-0","volume":"15","author":"S Rahman","year":"2019","unstructured":"Rahman S, Copeland WC. POLG-related disorders and their neurological manifestations. Nat Rev Neurol. 2019;15(1):40\u201352.","journal-title":"Nat Rev Neurol"},{"issue":"8067","key":"1444_CR72","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41586-025-08856-9","volume":"642","author":"S Valenzuela","year":"2025","unstructured":"Valenzuela S, Zhu X, Macao B, Stamgren M, Geukens C, Charifson PS, et al. Small molecules restore mutant mitochondrial DNA polymerase activity. Nature. 2025;642(8067):501\u20137.","journal-title":"Nature"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-025-01444-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-025-01444-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-025-01444-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T14:10:23Z","timestamp":1757340623000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-025-01444-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1444"],"URL":"https:\/\/doi.org\/10.1007\/s11910-025-01444-4","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"28 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"55"}}